Literature DB >> 19525483

Estimating progression rates for human papillomavirus infection from epidemiological data.

Mark Jit1, Nigel Gay, Kate Soldan, Yoon Hong Choi, William John Edmunds.   

Abstract

A Markov model was constructed in order to estimate type-specific rates of cervical lesion progression and regression in women with high-risk human papillomavirus (HPV). The model was fitted to age- and type-specific data regarding the HPV DNA and cytological status of women undergoing cervical screening in a recent screening trial, as well as cervical cancer incidence. It incorporates different assumptions about the way lesions regress, the accuracy of cytological screening, the specificity of HPV DNA testing, and the age-specific prevalence of HPV infection. Combinations of assumptions generate 162 scenarios for squamous cell carcinomas and 54 scenarios for adenocarcinomas. Simulating an unscreened cohort of women infected with high-risk HPV indicates that the probability of an infection continuing to persist and to develop into invasive cancer depends on the length of time it has already persisted. The scenarios and parameter sets that produce the best fit to available epidemiological data provide a basis for modeling the natural history of HPV infection and disease.

Entities:  

Mesh:

Year:  2009        PMID: 19525483     DOI: 10.1177/0272989X09336140

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  14 in total

1.  Calibrating models in economic evaluation: a seven-step approach.

Authors:  Tazio Vanni; Jonathan Karnon; Jason Madan; Richard G White; W John Edmunds; Anna M Foss; Rosa Legood
Journal:  Pharmacoeconomics       Date:  2011-01       Impact factor: 4.981

2.  Calibrating models in economic evaluation: a comparison of alternative measures of goodness of fit, parameter search strategies and convergence criteria.

Authors:  Jonathan Karnon; Tazio Vanni
Journal:  Pharmacoeconomics       Date:  2011-01       Impact factor: 4.981

3.  Calibration of complex models through Bayesian evidence synthesis: a demonstration and tutorial.

Authors:  Christopher H Jackson; Mark Jit; Linda D Sharples; Daniela De Angelis
Journal:  Med Decis Making       Date:  2013-07-25       Impact factor: 2.583

4.  The impact of liquid-based cytology in decreasing the incidence of cervical cancer.

Authors:  Randall K Gibb; Mark G Martens
Journal:  Rev Obstet Gynecol       Date:  2011

Review 5.  Role of IL-10 and TGF-β1 in local immunosuppression in HPV-associated cervical neoplasia.

Authors:  Kirvis Torres-Poveda; Margarita Bahena-Román; Claudia Madrid-González; Ana I Burguete-García; Víctor Hugo Bermúdez-Morales; Oscar Peralta-Zaragoza; Vicente Madrid-Marina
Journal:  World J Clin Oncol       Date:  2014-10-10

6.  Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study.

Authors:  S Rachel Skinner; Cosette M Wheeler; Barbara Romanowski; Xavier Castellsagué; Eduardo Lazcano-Ponce; M Rowena Del Rosario-Raymundo; Carlos Vallejos; Galina Minkina; Daniel Pereira Da Silva; Shelly McNeil; Vera Prilepskaya; Irina Gogotadze; Deborah Money; Suzanne M Garland; Viktor Romanenko; Diane M Harper; Myron J Levin; Archana Chatterjee; Brecht Geeraerts; Frank Struyf; Gary Dubin; Marie-Cécile Bozonnat; Dominique Rosillon; Laurence Baril
Journal:  Int J Cancer       Date:  2016-05-15       Impact factor: 7.396

7.  Inference of type-specific HPV transmissibility, progression and clearance rates: a mathematical modelling approach.

Authors:  Helen C Johnson; K Miriam Elfström; W John Edmunds
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

8.  Type-specific prevalence of high-risk human papillomavirus by cervical cytology and age: Data from the health check-ups of 7,014 Korean women.

Authors:  Min-Jeong Kim; Jin Ju Kim; Sunmie Kim
Journal:  Obstet Gynecol Sci       Date:  2013-03-12

9.  Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study.

Authors:  Unnop Jaisamrarn; Xavier Castellsagué; Suzanne M Garland; Paulo Naud; Johanna Palmroth; Maria Rowena Del Rosario-Raymundo; Cosette M Wheeler; Jorge Salmerón; Song-Nan Chow; Dan Apter; Julio C Teixeira; S Rachel Skinner; James Hedrick; Anne Szarewski; Barbara Romanowski; Fred Y Aoki; Tino F Schwarz; Willy A J Poppe; F Xavier Bosch; Newton S de Carvalho; Maria Julieta Germar; Klaus Peters; Jorma Paavonen; Marie-Cecile Bozonnat; Dominique Descamps; Frank Struyf; Gary O Dubin; Dominique Rosillon; Laurence Baril
Journal:  PLoS One       Date:  2013-11-19       Impact factor: 3.240

10.  Natural history of anal dysplasia in an HIV-infected clinical care cohort: estimates using multi-state Markov modeling.

Authors:  William C Mathews; Wollelaw Agmas; Edward R Cachay; Bard C Cosman; Christopher Jackson
Journal:  PLoS One       Date:  2014-08-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.